
News
For this purpose, 75 interviews were conducted with researchers, TTO officers, investors, small and large companies, clinicians, and cluster organizations. The book also contains experience-based input of the eight project partners and 14 Advisory Board members, who shared similar problems in developing and commercializing IVD-applicable biomarkers.